| dc.contributor.author | Einhaus, Jakob Franz |  | 
| dc.contributor.author | Pecher, Ann-Christin |  | 
| dc.contributor.author | Asteriti, Elisa |  | 
| dc.contributor.author | Schmid, Hannes |  | 
| dc.contributor.author | Secker, Kathy-Ann |  | 
| dc.contributor.author | Dürr-Störzer, Silke |  | 
| dc.contributor.author | Keppeler, Hildegard |  | 
| dc.contributor.author | Klein, Reinhild |  | 
| dc.contributor.author | Schneidawind, Corina |  | 
| dc.contributor.author | Henes, Jörg Christoph |  | 
| dc.contributor.author | Schneidawind, Dominik |  | 
| dc.date.accessioned | 2020-09-28T14:33:10Z |  | 
| dc.date.available | 2020-09-28T14:33:10Z |  | 
| dc.date.issued | 2020 |  | 
| dc.identifier.issn | 1478-6362 |  | 
| dc.identifier.uri | http://hdl.handle.net/10900/107266 |  | 
| dc.language.iso | en | de_DE | 
| dc.publisher | Bmc | de_DE | 
| dc.relation.uri | http://dx.doi.org/10.1186/s13075-020-02153-8 | de_DE | 
| dc.subject.ddc | 610 | de_DE | 
| dc.title | Inhibition of effector B cells by ibrutinib in systemic sclerosis | de_DE | 
| dc.type | Article | de_DE | 
| utue.quellen.id | 20200715072417_01121 |  | 
| utue.personen.roh | Einhaus, Jakob |  | 
| utue.personen.roh | Pecher, Ann-Christin |  | 
| utue.personen.roh | Asteriti, Elisa |  | 
| utue.personen.roh | Schmid, Hannes |  | 
| utue.personen.roh | Secker, Kathy-Ann |  | 
| utue.personen.roh | Duerr-Stoerzer, Silke |  | 
| utue.personen.roh | Keppeler, Hildegard |  | 
| utue.personen.roh | Klein, Reinhild |  | 
| utue.personen.roh | Schneidawind, Corina |  | 
| utue.personen.roh | Henes, Joerg |  | 
| utue.personen.roh | Schneidawind, Dominik |  | 
| dcterms.isPartOf.ZSTitelID | Arthritis Research & Therapy | de_DE | 
| dcterms.isPartOf.ZS-Issue | Article 66 | de_DE | 
| dcterms.isPartOf.ZS-Volume | 22 | de_DE | 
| utue.fakultaet | 04 Medizinische Fakultät | de_DE |